Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits.
Int J Surg Oncol., 2012:891067 (2012)
DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node-negative breast cancer.
Cancer., Feb;118(4):888-98 (2012)
Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT).
Int. J. Radiat. Oncol. Biol. Phys., Jun;80(2):385-91 (2011)
Intrafractional target motions and uncertainties of treatment setup reference systems in accelerated partial breast irradiation.
Int. J. Radiat. Oncol. Biol. Phys., Apr;79(5):1549-56 (2011)
Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of the Mammosite registry trial with intergroup study E5194.
Cancer., Mar;117(6):1149-55 (2011)
Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194.
Cancer., Mar;117(6):1156-62 (2011)
Improvement in interobserver accuracy in delineation of the lumpectomy cavity using fiducial markers.
Int. J. Radiat. Oncol. Biol. Phys., Nov;78(4):1127-34 (2010)
Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with bevacizumab.
Int. J. Radiat. Oncol. Biol. Phys., Feb;79(2):408-13 (2011)
Hypofractionation in adjuvant breast radiotherapy.
Breast., Jun;19(3):168-71 (2010)
Radiotherapy. Hypofractionation for breast cancer--clinical implications.
Nat Rev Clin Oncol., Jun;7(6):304-6 (2010)
Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy.
Breast Cancer Res. Treat., Apr;126(3):601-7 (2011)
Clinicopathologic presentation of Asian-Indian American (AIA) women with stage 0, I & II breast cancer.
J Immigr Minor Health., Feb;13(1):42-8 (2011)
Clinicopathologic significance of excision repair cross-complementation 1 expression in patients treated with breast-conserving surgery and radiation therapy.
Int. J. Radiat. Oncol. Biol. Phys., Mar;76(3):679-84 (2010)
Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.
Ann. Oncol., Oct;20(10):1653-9 (2009)
A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer.
Carcinogenesis., Nov;30(11):1910-5 (2009)
On the assay of brachytherapy sources.
Med Phys., Jun;34(6):1975-82 (2007)
Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression.
Int. J. Radiat. Oncol. Biol. Phys., Jan;70(1):35-42 (2008)
A strategy to objectively evaluate the necessity of correcting detected target deviations in image guided radiotherapy.
Med Phys., Nov;34(11):4340-7 (2007)
Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
Int. J. Radiat. Oncol. Biol. Phys., Jul;71(4):1006-13 (2008)
Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
Int. J. Radiat. Oncol. Biol. Phys., Nov;72(4):1056-63 (2008)